tert-Butyl 1H-pyrazol-3-ylcarbamate

Catalog No. :
ACNXUS059
CAS No. :
952674-76-9
Molecular Formula :
C8H13N3O2
Molecular Weight :
183.21

IUPAC Name:tert-butyl (1H-pyrazol-3-yl)carbamate

tert-Butyl 1H-pyrazol-3-ylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$58.00Login to see priceIn stockInquiry
1g95%$207.00Login to see priceIn stockInquiry
5g95%$695.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1H-pyrazol-3-ylcarbamate
IUPAC Nametert-butyl (1H-pyrazol-3-yl)carbamate
MDL No.MFCD14635783
Molecular FormulaC8H13N3O2
Molecular Weight183.21
SMILESO=C(OC(C)(C)C)NC1=NNC=C1
InChI KeyRZIAELOQCATLDL-UHFFFAOYSA-N
SynonymW12971 | A915697 | RZIAELOQCATLDL-UHFFFAOYSA-N | SCHEMBL14116753 | EN300-73169 | AKOS010652471 | tert-Butyl (1H-pyrazol-5-yl)carbamate | tert-Butyl 1H-pyrazol-5-ylcarbamate | tert-butyl 1H-pyrazol-3-ylcarbamate | SY036198 | AS-44921 | 3-(Boc-amino)pyrazol
CAS No.952674-76-9
PubChem CID57937381

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNXUS059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNXUS059 route product structure diagram
    ACNXUS059952674-76-9 In Stock
Inquiry

2. ACNXUS059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACNXUS059 route product structure diagram
    ACNXUS059952674-76-9 In Stock
Inquiry

Comments (0)